Related Experiment Video
Updated: Aug 9, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Peroxisome Proliferator-Activated Receptor-Targeted Therapies: Challenges upon Infectious Diseases
In Soo Kim1,2,3, Prashanta Silwal4, Eun-Kyeong Jo1,2,3
1Department of Microbiology, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea.
Abstract:
Peroxisome proliferator-activated receptors (PPARs) α, β, and γ are nuclear receptors that orchestrate the transcriptional regulation of genes involved in a variety of biological responses, such as energy metabolism and homeostasis, regulation of inflammation, cellular development, and differentiation. The many roles played by the PPAR signaling pathways indicate that PPARs may be useful targets for various human diseases, including metabolic and inflammatory conditions and tumors. Accumulating evidence suggests that each PPAR plays prominent but different roles in viral, bacterial, and parasitic infectious disease development. In this review, we discuss recent PPAR research works that are focused on how PPARs control various infections and immune responses. In addition, we describe the current and potential therapeutic uses of PPAR agonists/antagonists in the context of infectious diseases. A more comprehensive understanding of the roles played by PPARs in terms of host-pathogen interactions will yield potential adjunctive personalized therapies employing PPAR-modulating agents.
Insights
Peroxisome proliferator-activated receptors (PPARs) regulate energy, inflammation, and development. This review explores how PPARs impact infectious diseases and their therapeutic potential.
Area of Science:
- Molecular Biology
- Immunology
- Pharmacology
Background:
- Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors regulating diverse biological processes.
- PPARs are implicated in energy metabolism, inflammation, cellular development, and differentiation.
- Dysregulation of PPARs is linked to metabolic diseases, inflammation, and cancer.
Purpose of the Study:
- To review recent research on the role of PPARs in infectious diseases.
- To explore how PPARs modulate host-pathogen interactions and immune responses.
- To discuss the therapeutic potential of PPAR modulators in treating infections.
Main Methods:
- Literature review of recent studies on PPARs and infectious diseases.
- Analysis of experimental data on PPAR function in host-pathogen interactions.
- Synthesis of information on the clinical applications of PPAR agonists and antagonists.
Main Results:
- PPARs play distinct roles in the pathogenesis of viral, bacterial, and parasitic infections.
- PPAR signaling influences immune cell function and inflammatory responses during infection.
- Evidence suggests PPARs are critical regulators of host defense mechanisms.
Conclusions:
- Understanding PPARs' role in host-pathogen interactions is crucial for developing new therapies.
- PPAR agonists/antagonists represent promising adjunctive treatments for infectious diseases.
- Personalized therapies targeting PPAR pathways could enhance treatment outcomes for various infections.
Related Concept Videos
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Peroxisomes
Microorganisms in Medicine and Therapeutics
Targeted Cancer Therapies
There are several types of targeted therapies against...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Gene Regulation in Microbial Communities: Quorum Sensing

